Table 4 –
Predicted Probabilities of Survival, Stratified by Treatment Modality
| Full Model | Immortal Model* | Staging Model† | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 years | 99.1% | 94.5% | 94.4% | 99.0% | 93.8% | 94.2% | 98.3% | 92.4% | 91.8% |
| 2 years | 96.6% | 80.3% | 80.1% | 96.6% | 80.9% | 82.0% | 94.3% | 76.5% | 75.0% |
| 3 years | 93.1% | 63.5% | 63.1% | 93.5% | 66.0% | 67.8% | 89.2% | 59.4% | 57.1% |
| 4 years | 88.8% | 47.1% | 46.6% | 89.8% | 51.5% | 53.7% | 83.4% | 44.6% | 41.9% |
| 5 years | 84.2% | 33.6% | 33.1% | 85.9% | 39.2% | 41.6% | 77.9% | 32.3% | 29.6% |
LT = liver transplantation
*
Model adjusts for time-varying exposure status
†
Model restricted to patients with BCLC staging data (N = 432), and specifically those with BCLC stage 0, A, or B (n = 414)